Skip to main content

RESMED INC

For the period ended Mar 31, 2026. Filed May 1, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 1, 2026

RMD$234.11-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Changes in Equity (Unaudited)

PART I – FINANCIAL INFORMATIONItem 1

Condensed Consolidated Statements of Changes in Equity (Unaudited)

Common Stock · AdditionalPaid-in Capital · Treasury Stock · RetainedEarnings · AccumulatedOtherComprehensive Income (Loss) · Total
Shares · Amount · Shares · Amount
Balance, June 30, 2025190,311$761$2,033,599(43,926)$(2,073,292)$6,081,490$(74,699)$5,967,859
Common stock issued on exercise of options6918,204————8,205
Common stock issued on vesting of restricted stock units, net of shares withheld for tax10—(719)————(719)
Treasury stock purchases———(523)(150,010)——(150,010)
Stock-based compensation costs——21,160————21,160
Other comprehensive income (loss)——————13,98313,983
Net income—————348,536—348,536
Dividends declared ($0.60 per common share)—————(87,750)—(87,750)
Balance, September 30, 2025190,390$762$2,062,244(44,449)$(2,223,302)$6,342,276$(60,716)$6,121,264
Common stock issued on exercise of options55—9,498————9,498
Common stock issued on vesting of restricted stock units, net of shares withheld for tax2571(20,309)————(20,308)
Common stock issued on employee stock purchase plan112—22,621————22,621
Treasury stock purchases———(704)(176,996)——(176,996)
Stock-based compensation costs——28,938————28,938
Other comprehensive income (loss)——————30,85330,853
Net income—————392,593—392,593
Dividends declared ($0.60 per common share)—————(87,584)—(87,584)
Balance, December 31, 2025190,814$763$2,102,992(45,153)$(2,400,298)$6,647,285$(29,863)$6,320,879
Common stock issued on exercise of options48—4,865————4,865
Common stock issued on vesting of restricted stock units, net of shares withheld for tax4—(418)————(418)
Stock-based compensation costs——26,792————26,792
Treasury stock purchases———(673)(176,659)——(176,659)
Other comprehensive income (loss)——————4,9584,958
Net income—————398,732—398,732
Dividends declared ($0.60 per common share)—————(87,238)—(87,238)
Balance, March 31, 2026190,866$763$2,134,231(45,826)$(2,576,957)$6,958,779$(24,905)$6,491,911
PART I – FINANCIAL INFORMATIONItem 1

Condensed Consolidated Statements of Changes in Equity (Unaudited)

Common Stock · AdditionalPaid-inCapital · Treasury Stock · RetainedEarnings · AccumulatedOtherComprehensive Income (Loss) · Total
Shares · Amount · Shares · Amount
Balance, June 30, 2024189,565$588$1,896,604(42,664)$(1,773,267)$4,991,647$(251,529)$4,864,043
Adjustment to common stock—170(170)—————
Common stock issued on exercise of options92—8,383————8,383
Common stock issued on vesting of restricted stock units, net of shares withheld for tax5—(389)————(389)
Treasury stock purchases———(222)(50,005)——(50,005)
Stock-based compensation costs——20,156————20,156
Other comprehensive income (loss)——————119,374119,374
Net income—————311,355—311,355
Dividends declared ($0.53 per common share)—————(77,891)—(77,891)
Balance, September 30, 2024189,662$758$1,924,584(42,886)$(1,823,272)$5,225,111$(132,155)$5,195,026
Common stock issued on exercise of options63—6,904————6,904
Common stock issued on vesting of restricted stock units, net of shares withheld for tax2152(16,736)————(16,734)
Common stock issued on employee stock purchase plan109—19,973————19,973
Treasury stock purchases———(307)(74,986)——(74,986)
Stock-based compensation costs——22,634————22,634
Other comprehensive income (loss)——————(166,735)(166,735)
Net income—————344,622—344,622
Dividends declared ($0.53 per common share)—————(77,695)—(77,695)
Balance, December 31, 2024190,049$760$1,957,359(43,193)$(1,898,258)$5,492,038$(298,890)$5,253,009
Common stock issued on exercise of options7419,022————9,023
Common stock issued on vesting of restricted stock units, net of shares withheld for tax3—(364)————(364)
Treasury stock purchases———(314)(75,026)——(75,026)
Stock-based compensation costs——24,120————24,120
Other comprehensive income (loss)——————48,03448,034
Net income—————365,041—365,041
Dividends declared ($0.53 per common share)—————(77,704)—(77,704)
Balance, March 31, 2025190,126$761$1,990,137(43,507)$(1,973,284)$5,779,375$(250,856)$5,546,133
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.